IMP: BOD approved to extend the time to hold AGM 2020

Due to the outbreak of Coronavirus (Covid-19) pandemic, the BOD of Imexpharm Corporation approved to extend the time to hold the Annual General Meeting 2020, but no later than June 30, 2020. The details will be informed later.

HOSE

>   DNP: Change in shareholding of principal shareholder (United Asia Investment JSC) (09/04/2020)

>   NNG: Financial Statement FY 2019 (holding company) (09/04/2020)

>   TCT: TCT allowed to extend the time for holding AGM 2020 (09/04/2020)

>   TDG: Notice of the holding of Annual General Meeting 2020 (09/04/2020)

>   VPB: VPB allowed to extend the submission of financial statements (09/04/2020)

>   TTE: TTE allowed to extend the time for holding AGM 2020 (09/04/2020)

>   MSN: MSN allowed to extend the time for holding AGM 2020 (09/04/2020)

>   TNI: TNI allowed to delay the disclosure of 2019 audited financial statements (09/04/2020)

>   QCG: QCG allowed to delay the disclosure of 2019 audited financial statements (09/04/2020)

>   DIC: DIC allowed to delay the disclosure of 2019 audited financial statements (09/04/2020)